Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cardiac Biomarkers Predict CV Events in CAP

Key clinical point: Patients with community-acquired pneumonia with specific cardiac biomarkers were more likely to experience an early or late cardiovascular event.

Major finding: Cardiac biomarkers proendothelin-1 (odds ratio, 2.25; 95% confidence interval, 1.34-3.79), proADM (OR, 2.53; 95% CI, 1.53-4.20), proBNP (OR, 2.67; 95% CI, 1.59-4.49), and troponin T (OR, 2.70; 95% CI, 1.62-4.49) significantly predicted early cardiovascular events.

Study details: A prospective analysis of cardiac biomarkers for 730 patients who were hospitalized for community-acquired pneumonia up to 1-year follow-up.

Disclosures: This study was supported in part by funding from Instituto de Salud Carlos III, Sociedad Española de Neumología y Cirugía Torácica, and the Center for Biomedical Research Network in Respiratory Diseases. The authors report no relevant conflicts of interest.

Citation:

Menéndez R et al. Chest. 2019 Aug 2. doi: 10.1016/j.chest.2019.06.040.